4.6 Letter

Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 90, Issue 11, Pages 1293-+

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2018-320287

Keywords

-

Funding

  1. Merck
  2. Euroimmun
  3. Shire
  4. Novartis
  5. Biogen
  6. Celgene
  7. TEVA
  8. Genzyme
  9. Sanofi-Aventis
  10. Austrian Science Promotion Agency (FFG)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available